MiR-206 suppresses the deterioration of intrahepatic cholangiocarcinoma and promotes sensitivity to chemotherapy by inhibiting interactions with stromal CAFs
2022
-
Correction
-
Source
-
Cite
-
Save
0
References
0
Citations
NaN
KQI